SEC Filings for SPDR Series Trust S&P Biotech (XBI)

$ 105.81   -0.24 (-0.23%) Volume: 5.22m 1:31 PM EDT May 26, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
497Definitive materials105/21/2020
497KSummary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(K)105/21/2020
497KSummary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(K)105/21/2020
485BPOSPost-effective amendment [Rule 485(b)]305/14/2020
485APOSPost-effective amendment [Rule 485(a)]16505/11/2020
485BXTNew effective date for post-effective amendment [Rule 485(b)(1)(iii)]304/30/2020
497JCertification of no change in definitive materials104/30/2020
497KSummary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(K)804/28/2020
497KSummary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(K)804/28/2020
497KSummary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(K)804/28/2020
497KSummary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(K)804/28/2020
497KSummary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(K)804/28/2020
485BPOSPost-effective amendment [Rule 485(b)]24204/24/2020
497Definitive materials104/22/2020
497Definitive materials104/22/2020
<<
First
<
Prev
123456789101112131415